,AT2AT2

Wenxiang Wang1,2,3, Sida Cheng1, Hongchengcheng Chen1

  • 1Department of Thoracic Surgery, Peking University People's Hospital, Beijing, Beijing, China.

概括

在多重原发性肺癌 (MPLC) 中,非响应性病变中的II型膜上皮细胞 (AT2) 通过MIF-SIAE通路抑制三级淋巴体结构 (TLS) 内的B细胞,阻碍免疫治疗的有效性.